- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: radioactive iodine refractory thyroid cancer
Total 92613 results
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Italy, Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Poland, United States, United Kingdom, Turkey, Belgium, Thailand, Czechia
-
Ruijin HospitalNot yet recruiting
-
GluBio Therapeutics Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Shanghai Jiao Tong University School of MedicineRecruitingMedullary Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Adrenal Cortical Carcinoma | Thymic Neuroendocrine CarcinomaChina
-
Massachusetts General HospitalPfizerRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Zhejiang Cancer HospitalRecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment FailedChina
-
University of CalgaryAlberta Health services; Qualisure Diagnostics Inc.Not yet recruitingPapillary Thyroid CancerCanada
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
Caribou Biosciences, Inc.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Hamilton Health Sciences CorporationMcMaster University; Ontario Clinical Oncology Group (OCOG)Recruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingLung CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRelapsed/Refractory PTCLT With at Least One Line of Prior Systemic TherapyChina
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...RecruitingMantle Cell LymphomaChina
-
The Affiliated Hospital of Xuzhou Medical UniversityGuangzhou Bioresette Biomedical Technology Co., Ltd.Recruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingSolid Tumor | Neuroblastoma | Solid Tumor, Adult | Primary Brain Tumor | Solid Carcinoma | Low-grade Glioma | Central Nervous System Tumor | Refractory Cancer | CNS Tumor, Adult | CNS Tumors | NF1 | Plexiform Neurofibroma | CNS Tumor, Childhood | Optic Pathway Gliomas | MAP Kinase Family Gene MutationUnited States
-
National Cancer Institute (NCI)RecruitingMultiple Myeloma | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
The Affiliated Hospital of Xuzhou Medical UniversityGuangzhou Bioresette Biomedical Technology Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterSanofi US Services, IncRecruiting
-
National Cancer Institute (NCI)RecruitingMetastatic Colorectal Adenocarcinoma | Refractory Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8United States
-
Wuhan Union Hospital, ChinaRecruitingMetastatic Colorectal Cancer | FruquintinibChina
-
Min Suk ChaeNot yet recruiting
-
Nexcella Inc.Not yet recruitingLight Chain (AL) AmyloidosisUnited States
-
Regeneron PharmaceuticalsRecruitingFollicular Lymphoma (FL)Spain, United States, Australia, Turkey, Israel, Thailand, United Kingdom, Taiwan, Belgium, Poland, Chile, Italy
-
UNC Lineberger Comprehensive Cancer CenterBellicum Pharmaceuticals; University Cancer Research Fund at Lineberger Comprehensive...RecruitingHead and Neck Cancer | Relapse | Refractory Cancer | RecurrentUnited States
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
UNC Lineberger Comprehensive Cancer CenterRecruitingHodgkin Lymphoma | Relapse | RefractoryUnited States
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Innate PharmaRecruitingNon Hodgkin LymphomaFrance, United States, Australia
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRecurrence | Surgery | Thyroid CancerChina
-
M.D. Anderson Cancer CenterNot yet recruitingThyroid LobectomyUnited States
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
Hoffmann-La RocheRecruitingLymphomaKorea, Republic of, United States, Spain, France, Brazil, China, Canada, Australia, Sweden, Taiwan, Italy, United Kingdom
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingRelapsed/Refractory Marginal Zone LymphomaChina
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
Power Life Sciences Inc.Not yet recruitingMedullary Thyroid CancerUnited States
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)RecruitingThyroid CancerUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingLiver Metastasis Colon CancerChina
-
Institute for Clinical and Experimental MedicineUniversitaire Ziekenhuizen KU Leuven; University Hospital, Martin; Sana-Klinikum... and other collaboratorsRecruitingEsophageal Cancer | GastroparesisFrance, Czechia
-
AbbVieRecruitingAcute Myeloid LeukemiaUnited States, Israel, Japan, Australia, Korea, Republic of
-
M.D. Anderson Cancer CenterRecruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-hodgkin's LymphomaChina
-
Peking University Third HospitalNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Colorectal CancerChina
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingBreast Cancer | Postsurgical Acquired Absence of OrganRussian Federation
-
University of WashingtonIncyte CorporationRecruitingMerkel Cell Carcinoma | Clinical Stage IV Merkel Cell Carcinoma AJCC v8 | Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States